Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells. [electronic resource]
Producer: 20050311Description: 596-603 p. digitalISSN:- 0146-0404
- Adoptive Transfer
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Antigens, CD -- immunology
- Apoptosis -- drug effects
- Autoimmune Diseases -- immunology
- Cell Proliferation
- Eye Proteins -- immunology
- Female
- Immunization
- Lymphocyte Activation
- Mice
- Receptors, Nerve Growth Factor -- immunology
- Receptors, Tumor Necrosis Factor -- immunology
- Retinol-Binding Proteins -- immunology
- Specific Pathogen-Free Organisms
- T-Lymphocytes -- immunology
- T-Lymphocytes, Cytotoxic -- immunology
- Tumor Necrosis Factor Receptor Superfamily, Member 9
- Uveitis, Posterior -- immunology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.